This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Explore the wash sale rule as it applies to dividend ETFs and strategies to avoid unnecessary tax complications.
12,423 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Arthur Hayes faces swift backlash after signaling bullish bets on several coins, only to exit large positions soon af...
SpaceX announces a year-long insider lockup with a 15-date unlock schedule to follow. The move tests liquidity expect...
A fresh market clock shows nine American metro areas moving toward a buyer's market, signaling more leverage for buye...
A once-celebrated treasure hunter exits federal custody after a decade behind bars, as investors weigh the legal fall...
A notable fund exited its position in a medical device stock, locking in gains as the shares slipped over the past ye...
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Nvidia is betting on a future where it sells complete AI production lines, not just chips. This shift could redefine ...
Google bought YouTube for $1.65 billion in 2006. The founders walked away with hundreds of millions, and today YouTub...
As AI hype accelerates, Clarivate (CLVT) quietly leans on its defensible data assets to reduce debt and position for ...
Lenders say the yellow math explain about approach reveals how upfront costs and inflation expectations steer builder...
Opendoor expands its cash-offer toolkit through a RealScout integration, framing it as opendoor’s ‘grand reopening’: ...